⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AUTL News
Autolus Therapeutics plc American Depositary Share
Form 8-K
sec.gov
AUTL
Autolus Therapeutics Reports Second Quarter 2026 Financial Results and Business Updates
globenewswire.com
AUTL
Autolus Therapeutics to Report Second Quarter 2026 Financial Results and Host Conference Call on August 11, 2026
globenewswire.com
AUTL
Form 8-K
sec.gov
AUTL
Autolus Therapeutics Reports Preliminary Second Quarter 2026 Net Product Revenue and Announces Credit Facility of up to $250 Million with Perceptive Advisors
globenewswire.com
AUTL
Form 8-K
sec.gov
AUTL
Autolus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
AUTL
Autel Announces Integration of NASTF SDRM Validation Protocols into Key and Immobilizer Programming Tools
prnewswire.com
AUTL
Form 8-K
sec.gov
AUTL
Autolus Therapeutics to Participate in Upcoming Investor Conference
globenewswire.com
AUTL